Article info

Download PDFPDF
Primary photodynamic therapy with verteporfin for pigmented posterior pole cT1a choroidal melanoma: a 3-year retrospective analysis

Authors

  • Ido Didi Fabian Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK Ocular Oncology Service, Goldschleger Eye Institute, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Andrew W Stacey Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK Department of Ophthalmology, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Lamis Al Harby Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Amit K Arora Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Mandeep S Sagoo Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital, London, UK Institute of Ophthalmology, University College London, London, UK PubMed articlesGoogle scholar articles
  • Victoria M L Cohen Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital, London, UK Institute of Ophthalmology, University College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ido Didi Fabian, Moorfields Eye Hospital, London EC1V 2PD, UK; didifabian{at}gmail.com
View Full Text

Citation

Fabian ID, Stacey AW, Harby LA, et al
Primary photodynamic therapy with verteporfin for pigmented posterior pole cT1a choroidal melanoma: a 3-year retrospective analysis

Publication history

  • Received December 13, 2017
  • Revised January 26, 2018
  • Accepted February 1, 2018
  • First published February 13, 2018.
Online issue publication 
November 22, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.